Rekvina Laboratories Limited (BOM:526075)
India flag India · Delayed Price · Currency is INR
25.30
0.00 (0.00%)
At close: Jul 24, 2026

Rekvina Laboratories Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
0.150.250.10.10
Cash & Short-Term Investments
0.150.250.10.10
Cash Growth
-39.04%164.21%-3.06%2563.04%-82.48%
Accounts Receivable
5.97----
Receivables
5.97----
Other Current Assets
5.770.07---
Total Current Assets
11.890.330.10.10
Property, Plant & Equipment
---1.461.46
Long-Term Investments
---0.460.46
Total Assets
11.890.330.12.021.92

Liabilities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
3.941.071.141.061.76
Accrued Expenses
5.50.110.010.020.03
Short-Term Debt
14.732.470.40.81-
Other Current Liabilities
--0.50-
Total Current Liabilities
24.173.652.051.891.78
Total Liabilities
24.173.652.051.891.78

Shareholders' Equity

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
30.1430.1430.1430.1430.14
Retained Earnings
-42.42-33.46-32.09-30.01-30
Shareholders' Equity
-12.28-3.32-1.950.130.14
Total Liabilities & Equity
11.890.330.12.021.92

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
14.732.470.40.81-
Net Cash (Debt)
-14.57-2.22-0.3-0.720
Net Cash Growth
-----82.48%
Net Cash Per Share
-2.40-0.37-0.05-0.120.00
Filing Date Shares Outstanding
6.056.036.036.036.07
Total Common Shares Outstanding
6.056.036.036.036.07
Working Capital
-12.28-3.32-1.95-1.79-1.78
Book Value Per Share
-2.03-0.55-0.320.020.02
Tangible Book Value
-12.28-3.32-1.950.130.14
Tangible Book Value Per Share
-2.03-0.55-0.320.020.02
Land
---0.170.17
Buildings
---2.032.02
Machinery
---2.92.9